Clinical Trials Directory

Trials / Completed

CompletedNCT01155882

Registry Study - Whipple at the Splenic Artery

Whipple at the Splenic Artery - A Procedure for Ductal Adenocarcinoma of the Pancreas With Extensive Involvement of the Porto-Mesenteric Axis: A Registry Study

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine how effective Whipple at the Splenic Artery (WATSA).

Detailed description

Primary The primary objective of this registry study is to collect clinical data from patients who undergo the WATSA procedure. Specific hypotheses to be tested are * To determine how effective Whipple at the Splenic Artery (WATSA) is at resecting tumors with negative microscopic margins (R0) at the resection line on the pancreas and at the tangential posterior, uncinate, and venous margins. * To determine if WATSA can be performed within the usual range of morbidity and mortality (30 day postoperative mortality) for a standard a Whipple procedure. Secondary The secondary objectives of this registry study are to * To determine the survival/recurrence rates at 2 years. * To determine the effect of occlusion of the splenic vein at the confluence.

Conditions

Interventions

TypeNameDescription
PROCEDUREWhipple at the Splenic Artery (WATSA)

Timeline

Start date
2010-09-20
Primary completion
2019-01-16
Completion
2019-01-16
First posted
2010-07-02
Last updated
2019-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01155882. Inclusion in this directory is not an endorsement.